BC
BHVN

Burleson & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Burleson & Co’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-61
Closed -$4K – 426
2021
Q1 		$4K Buy
+61
New +$4.93K ﹤0.01% 298

Other funds holding BHVN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Burleson & Co's BHVN Position: Q2 2021 in Review

Burleson & Co sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2021, closing a stake of 61 shares — an estimated $4K sold.

Burleson & Co first reported a position in BHVN in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 223 funds tracked by Wall St. Rank hold BHVN as of Q2 2021.

  • Burleson & Co reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2021 after selling out during the quarter.
  • Burleson & Co sold 61 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2021, an estimated $4K.
  • Burleson & Co first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2021 and held it in 1 quarter.
  • Burleson & Co's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4K in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2021.

Based on Burleson & Co's 13F filing for Q2 2021, filed 22 Jul 2021.